在电治疗后治疗耐药抑郁症中阿迪波金,树脂素和BDNF度的变化
Agnieszka Permoda-Pachuta1, Magda Malewska-Kasprzak2, Maria Skibińska3
1Department of Psychiatry, Medical University of Lublin, 20-439 Lublin, Poland.
Brain sciences
|October 28, 2023
概括
电疗法 (ECT) 改变了治疗耐药性抑郁症患者的阿迪波内克丁,抵抗素和BDNF水平. 这些变化与症状改善相关,这表明阿迪波金可以作为ECT反应的生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 生物化学 生物化学
背景情况:
- 管理耐药性抑郁症仍然是精神病学中的一个重大挑战.
- 电疗法 (ECT) 是对严重抑郁症的高度有效治疗方法,但潜在的生物机制需要进一步阐明.
- 神经炎症假说表明,炎症在抑郁症病理生理学中起着作用.
研究的目的:
- 在接受ECT的抗抑郁药耐药性抑郁症患者中,研究抗炎性阿迪波涅丁,促炎性抵抗素和BDNF的度.
- 探索这些生物标志物与治疗反应之间的关系,考虑抑郁症类型,性别和缓解状态.
主要方法:
- 用ELISA测量了52名单极性或双极性情绪障碍患者在ECT前后的血清度.
- 统计分析包括基于抑郁症类型,性别和缓解成就的比较.
主要成果:
- ECT治疗导致阿迪波内克丁,抵抗素和BDNF度发生变化.
- 这些变化与抑郁症状严重程度的改善相关.
- 这些变化的程度因抑郁症的类型而异.
结论:
- 阿迪波金具有潜力作为监测疾病进程和抑郁症中对ECT反应的生物标志物.
- 虽然并非所有变化都达到统计学意义,但阿迪波金需要进一步研究其在治疗耐药性抑郁症中的作用.
相关概念视频
Electroconvulsive Therapy
47
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
47
Antidepressant Drugs: MAOIs and Other Agents
254
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
254
Depression: Overview
256
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
256
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Depressive Disorders: Etiology
104
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
104
Antidepressant Drugs: Overview
524
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
524


